AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II

Kidney International, Supplement

Volumn 67, Issue 93, 2005, Pages

  Cediel, Eva ^b   De Las Heras, Natalia ^b   Sanz Rosa, David ^b   Velasco, Olga ^b   Cachofeiro, Victoria ^b   Lahera, Vicente ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b NONE

Author keywords

Angiotensin II; Angiotensin II blockade; Catecholamines; Endothelin 1; Hypertension; Kidney; Thromboxane A2; Vasoconstriction

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CATECHOLAMINE DERIVATIVE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; IFETROBAN; IRBESARTAN; N ACETYL 10,11 DIHYDRO 5H DIBENZO[A,D]CYCLOHEPTEN 5 YLGLYCYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; PRAZOSIN; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; BIPHENYL DERIVATIVE; CATECHOLAMINE; POTASSIUM CHLORIDE; TETRAZOLE DERIVATIVE; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; HYPERTENSION; KIDNEY PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION; ANIMAL; ARTICLE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; KIDNEY CIRCULATION; WISTAR KYOTO RAT; KIDNEY TUBULE PRESSURE;

ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; MALE; POTASSIUM CHLORIDE; PRAZOSIN; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENAL CIRCULATION; TETRAZOLES; THROMBOXANE A2; VASOCONSTRICTOR AGENTS;

EID: 10944234531     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.09302.x     Document Type: Conference Paper

References (29)

1. PARVING HH: Hypertension and diabetes: The scope of the problem. Blood Press (Suppl 2):25-31, 2001
2. MA L, FOGO AB: Role of angiotensin II in glomerular injury. Semin Nephrol 21:544-553, 2001
3. UNGER T: The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89:3-9, 2002
4. NASJLETTI A. ARTHUR C: Corcoran Memorial Lecture. The role of eicosanoids in angiotensin-dependent hypertension. Hypertension 31:194-200, 2000
5. WOLF G, ZIYADEH FN: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56:393-405, 1999
6. SCHIFFRIN EL: Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 14:83S-89S, 2001
7. MISTRY M, NASJLETTI A: Contrasting effect of thromboxane synthase inhibitors and a thromboxane receptor antagonist on the development of angiotensin II-salt-induced hypertension in rats. J Pharmacol Exp Ther 253:90-94, 1990
8. D'USCIO LV, MOREAU P, SHAW S, et al: Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension. Hypertension 29:435-441, 1997
9. CHATZIANTONIOU C, DANIELS FH, ARENDHORST WJ: Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol 259:F372-382, 1990
10. WILCOX CS, WELCH WJ: Thromboxane mediation of the presser response to infused angiotensin II. Am J Hypertens 3:242-249, 1990
11. 2 analogue in aortic rings from spontaneously hypertensive rats: Role of nitric oxide. J Hypertens 12:1677-1684, 1997
12. 2 in renal vasoconstriction induced by angiotensin II in diabetes and hipertension. Kidney Int 62(Suppl 82):S2-S7, 2002
13. MAESO R, RODRIGO E, MUÑOZ-GARCÍA R, et al: Chronic treatment with losartan ameliorates vascular dysfunction induced by aging in spontaneously hypertensive rats. J Hypertens 16:665-672, 1998
14. FARINA NK, HODGSON WC, WIDDOP RE: Vascular reactivity to angiotensin 11 in blood-perfused kidneys of hypertensive diabetic rats. Eur J Pharmacol 310:185-191, 1996
15. FINK GD, BRODY MJ: Renal vascular resistance and reactivity in the spontaneously hypertensive rat. Am J Physiol 237:F128-132, 1979
16. KOST CK JR., KERZER WA, LI P, JACKSON EK: Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J Pharmacol Exp Ther 269:82-88, 1994
17. VYAS SJ, JACKSON EK: Angiotensin II: Enhanced renal responsiveness in young genetically hypertensive rats. J Pharmacol Exp Ther 273:768-777, 1995
18. ARENDSHORST WJ, BEIERWALTES WH: Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol 236:F246-251, 1979
19. FINK GD, BRODY MJ: Renal vascular resistance and reactivity in the spontaneously hypertensive rat. Am J Physiol 237:F128-132, 1979
20. MASUYAMA Y, NISHIMURA T, NISHIO I, KUCHII M: Noradrenaline clearance in hypertensive patients with various degrees of renal function. Clin Sci (Lond) 57(Suppl 5):213s-215s, 1979
21. COLLIS MG, DE MAY C, VANHOUTTE PM: Enhanced release of noradrenaline in the kidney of the young spontaneously hypertensive rat. Clin Sci (Lond) 57(Suppl 5):233s-234s, 1979
22. DOHI Y, HAHN AW, BOULANGER CM, et al: Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 19:131-137, 1992
23. SHIBOUTA Y, INADA Y, TERASHITA Z, et al: Angiotensin-II-stimulated release of thromboxane A2 and prostacyclin (PGI2) in isolated, perfused kidneys of spontaneously hypertensive rats. Biochem Pharmacol 28:3601-3609, 1979
24. LIN L, NASJLETTI A: Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction. Hypertension 18:158-164, 1991
25. DUMONT Y, D'AMOURS M, LEBEL M, LARIVIERE R: Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats. J Hypertens 19:1479-1487, 2001
26. BOEMKE W, HOCHER B, SCHLEYER N, et al: Hemodynamic, renal and endocrine responses to acute ET (A) blockade at different angiotensin II plasma levels. Am J Physiol 280:R1322-1331, 2001
27. RUAN X, ARENDHORST WJ: Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats. Am J Physiol 270:F945-952, 1996
28. ABE T, TAKEUCHI K, TAKAHASHI N, et al: Rat Kidney thromboxane receptor: molecular cloning, signal transduction and intrarenal expression localization. J Clin Invest 96:657-664, 1995
29. MURPHY TJ, ALEXANDER RW, GRIENDLING KK, et al: Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351:233-236, 1991